Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Biomaterials. 2014 Jul 29;35(32):8960–8969. doi: 10.1016/j.biomaterials.2014.07.011

Fig. 6.

Fig. 6

Gene expression of collagens and matrix metalloproteinases (MMPs) in human iPSC-derived SMCs with growth factor or cytokine treatment. (A) Gene expression of collagen1A1 and collage3A1 under 5 ng/ml of TGF-β1 treatment for 24 h. (B) Gene expression of MMP 2, 3, 9 and 12 in response to 10 ng/ml IL-1β treatment for 24 h. *, P < 0.05 vs vehicle control; **, P < 0.01 vs vehicle control.